Skip to main content

UNC Men’s Basketball Coach Roy Williams Speaks to Medicine Residents at Grand Rounds

November 16, 2017
Coach Roy Williams spoke to medicine residents at Grand Rounds last week, giving his highest praise for an education program that continues to develop leaders in medicine.

Dr. John Buse leads clinical trial of new diabetes treatment

November 14, 2017
The study is designed to evaluate whether TTP399 is well tolerated when administered as an add-on to insulin therapy and can improve daily glucose profiles and HbA1c in people living with type 1 diabetes.

New study aims to reduce opioid use while managing chronic pain

November 14, 2017
A principal investigator of the study is UNC’s Dr. Paul Chelminski, from the division of general medicine and clinical epidemiology, who has extensive experience studying best practices of prescribing and managing long-term opioid use.

Lupus Patients Now Have the Option to Administer Benlysta at Home

November 9, 2017
Lupus patients who previously needed to visit an infusion center to receive the drug Benlysta, now have the option to administer the medicine themselves at home using a novel "auto-injector" device, thanks in part to the efforts of Dr. Saira Sheikh, a UNC rheumatologist and allergist/immunologist who directs the lupus...

Defining the Burden of Hepatitis in the Democratic Republic of the Congo

November 9, 2017
Hepatitis C virus is a curable infectious disease, but treatment remains unavailable in resource-limited settings like the Democratic Republic of the Congo (DRC). The DRC Ministry of Health asked the University of North Carolina at Chapel Hill (UNC) to help determine the burden of infection and find a way to...

Kelli Allen, PhD, Investigates Pain Management Interventions for the Military and Veterans

November 9, 2017
Members of the military and veterans are disproportionally affected by pain, and the government is searching for ways to help them deal with this widespread and growing problem. New research being conducted thanks to multiple grants recently awarded by the US Department of Health and Human Services, the US Department...

Smart Artificial Beta Cells Could Lead to New Diabetes Treatment

November 2, 2017
In lab experiments and animal models, UNC and NC State researchers led by Zhen Gu, PhD, designed synthetic beta cells to secrete insulin in response to high blood sugar.

Simple Genetic Test Promises Better Outcomes in Heart Stent Patients

November 2, 2017
A study co-authored by Rick Stouffer, III, MD, the Henry A. Foscue Distinguished Professor of Medicine, chief of cardiology at UNC, highlights potential of personalized medicine in patients with cardiovascular disease.

Medicine Chair Ronald J. Falk, MD, Will Receive the John P. Peters Award

November 1, 2017
The American Society of Nephrology presents Department of Medicine Chair Ronald J. Falk, MD, FASN, with the John P. Peters Award this Saturday, November 4, 2017.

Willis Co-Authors American Heart Association Scientific Statement

October 26, 2017
UNC McAllister Heart Institute member Monte Willis, MD, is a co-author of a scientific statement from the American Heart Association regarding the burden of heart disease among African Americans. Heart disease is the leading killer of all Americans, but in African Americans, heart disease develops earlier, and deaths from heart...

UNC McAllister Heart Institute Turns Damaged Heart Tissue Back into Healthy Heart Muscle

October 26, 2017
Publishing their work in Nature, UNC School of Medicine researchers with the UNC McAllister Heart Institute show how their new research platform helped them discover new cell subpopulations and crucial cellular players in the process of turning damaged heart tissue back into healthy heart muscle. The research platform could be...

Jensen and Colleagues Identify Underlying Causes of Cardiotoxicity of New Therapies Used to Treat Cancers.

October 26, 2017
Brian Jensen, MD, associate professor of medicine and pharmacology, and colleagues identified for the first-time mechanisms underlying the cardiotoxicity of kinase inhibitors used to treat cancer.